Patent · US Active

Methylated markers for colorectal cancer

US11486007B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignees

Quest Diagnostics Investments LLC · US
CLINICAL GENOMICS PTY LTD · AU

Inventors

Susanne Pedersen · Richmond, AU
Lawrence Charles Lapointe · Forbes, AU
Rohan Baker · Forbes, AU
Amber C. Donahue · Rancho Santa Margarita, US
Yen-lin Peng · Mission Viejo, US
Frederic Waldman · San Francisco, US

Key dates

Filing date	Jun 3, 2015
Grant date	Nov 1, 2022
Priority date	—
Expiry date	Aug 24, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein is a combination of genomic sequences whose methylation patterns have utility for the improved detection and differentiation between colorectal neoplasms. Further disclosed herein are methods, nucleic acids and kits for detecting or differentiating between colorectal neoplasms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.